Biochemical estimation of infarct size

Heart

Volumn 97, Issue 3, 2011, Pages 169-170

  Collinson, Paul O ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE MB; TROPONIN I; TROPONIN T;

DIAGNOSTIC VALUE; EDITORIAL; GOLD STANDARD; HEART INFARCTION SIZE; HEART INJURY; HUMAN; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; HUMANS; MYOCARDIAL INFARCTION; PROGNOSIS; TROPONIN I; TROPONIN T;

EID: 78651245870     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.212175     Document Type: Editorial

References (14)

1. Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation 2007;116:2634-53.
2. Groth T, Hakman M, Sylven C. Prediction of myocardial infarct size from early serum myoglobin observations. Scand J Clin Lab Invest 1987;47:599-603. (Pubitemid 18013980)
3. Hackel DB, Reimer KA, Ideker RE, et al. Comparison of enzymatic and anatomic estimates of myocardial infarct size in man. Circulation 1984;70:824-35.
4. Gibbons RJ, Valeti US, Araoz PA, et al. The quantification of infarct size. J Am Coll Cardiol 2004;44:1533-42.
5. Christenson RH, Vollmer RT, Ohman EM, et al. Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction. TAMI Study Group. Am J Cardiol 2000;85:543-7.
6. Turer AT, Mahaffey KW, Gallup D, et al. Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST- segment elevation myocardial infarction. Curr Control Trials Cardiovasc Med 2005;6:12.
7. Rao AC, Collinson PO, Canepa-Anson R, et al. Troponin T measurement after myocardial infarction can identify left ventricular ejection of less than 40%. Heart 1998;80:223-5.
8. Rao AC, Collinson PO, Rose AJ, et al. Prospective evaluation of the role of routine cardiac troponin T measurement to identify left ventricular ejection fraction <40% after first myocardial infarction. Heart 2003;89:559-60.
9. Hallen J, Buser P, Schwitter J, et al. Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation myocardial infarction. Am J Cardiol 2009;104:1472-7.
10. Giannitsis E, Steen H, Kurz K, et al. Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T. J Am Coll Cardiol 2008;51:307-14.
11. Vasile VC, Babuin L, Giannitsis E, et al. Relationship of MRI-determined infarct size and cTnI measurements in patients with ST-elevation myocardial infarction. Clin Chem 2008;54:617-19.
12. Di Chiara A, Dall'Armellina E, Badano LP, et al. Predictive value of cardiac troponin-I compared to creatine kinase-myocardial band for the assessment of infarct size as measured by cardiac magnetic resonance. J Cardiovasc Med (Hagerstown) 2010;11:587-92.
13. Jolly SS, Shenkman H, Brieger D, et al. Quantitative troponin and death, cardiogenic shock, cardiac arrest and new heart failure in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS): insights from the Global Registry of Acute Coronary Events. Heart 2011;97:197-202.
14. Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J 2007;28:1598-660.